NEW YORK ─ GenMark Diagnostics' shares rose 27 percent to $21.47 in Thursday morning trading on the Nasdaq following a report that it has been approached by potential acquirers.
Investors went on a buying spree after Bloomberg, citing unnamed sources, reported Wednesday evening that Carlsbad, California-based GenMark is working with a financial advisor on a potential sale.
GenMark told 360Dx that in accordance with its policy, it doesn't comment on rumors.